Dr. Dental Care

Description

The provided data does not specify the chemical name, physical characteristics, or inactive ingredients of the drug. Therefore, a detailed description cannot be formulated based on the available information. Further details are required to create a comprehensive description.

Uses and Indications

This drug is indicated for oral hygiene purposes. It is administered by holding a suitable amount (10-15 ml) in the mouth for approximately 30 seconds, after which it should be spat out. Following this, it is recommended to brush the teeth with a toothbrush to ensure optimal oral care.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For dental use only. The dosage and administration of the product should be determined by the healthcare professional based on the specific needs of the patient. It is essential to follow the recommended guidelines for preparation and administration to ensure optimal efficacy and safety.

Healthcare professionals should ensure that the product is prepared according to the manufacturer's instructions prior to administration. The method of administration should be appropriate for the intended dental application, and care should be taken to adhere to the recommended dosing intervals.

Patients should be monitored for any adverse reactions following administration, and adjustments to the dosage may be necessary based on individual patient response and clinical judgment.

Contraindications

There are no contraindications listed for the use of this product. It is important to evaluate each patient's individual circumstances and medical history when considering treatment options.

Warnings and Precautions

Caution is advised when using this toothpaste due to its fluoride content of 90.5 ppm. Users should take care to avoid swallowing the toothpaste and are encouraged to rinse their mouths thoroughly after use. In the event of gum or mouth damage resulting from the use of this product, it is imperative to discontinue use and seek consultation from a healthcare professional, such as a doctor or dentist.

For children under the age of six, it is recommended to use only a small amount of toothpaste, approximately the size of a pea, and to ensure that usage is supervised by a guardian to prevent sucking or swallowing. If a child under six years old ingests a large quantity of toothpaste, immediate consultation with a physician or dentist is necessary. Additionally, this product should be kept out of the reach of children under six years old to prevent accidental ingestion.

This toothpaste contains sodium benzoate, which may cause slight irritation to the skin, eyes, and mucous membranes. To maintain the integrity and quality of the product, users should refrain from altering the container. Furthermore, the presence of fluoride necessitates guidance from parents or adults when the product is used by children.

Side Effects

Patients receiving treatment with sodium benzoate may experience slight irritation to the skin, eyes, and mucous membranes. This reaction has been noted in clinical settings and should be monitored. It is advisable for healthcare providers to inform patients about the potential for these irritations and to take appropriate precautions to minimize exposure to these areas during administration.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources as new data may emerge.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Dental Care (allantoin, sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be supervised when using this product, particularly those under the age of six years. It is recommended that a small amount of toothpaste, approximately the size of a pea, be used at a time to minimize the risk of swallowing. In the event that a child under six years old swallows a large amount, immediate consultation with a physician or dentist is advised.

Due to the presence of fluoride in this product, guidance from parents or guardians is essential to ensure safe usage among children. Additionally, it is crucial to keep this product out of reach of children under six years old to prevent accidental ingestion.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. There may be potential risks to the fetus, and further studies are needed to determine safety. No specific dosage modifications are provided for pregnant individuals. It is recommended that this product be used only if clearly needed and after a thorough discussion with a healthcare professional.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The effects on the nursing infant are not well studied; thus, the risks versus benefits should be considered.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In cases of overdosage, immediate medical consultation is essential, particularly for pediatric patients. If a child under the age of 6 years ingests a significant quantity of the medication, it is imperative to seek advice from a physician or dentist without delay.

Healthcare professionals should be vigilant for potential symptoms that may arise from overdosage, although specific symptoms were not detailed in the provided information. The management of overdosage should be guided by clinical judgment and may involve supportive care and symptomatic treatment as necessary.

In all instances of suspected overdosage, it is crucial to assess the patient's condition thoroughly and implement appropriate interventions based on the severity of the situation and the specific circumstances surrounding the ingestion.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with children accessing the medication, including serious health consequences. Providers should encourage patients to store the medication in a secure location and to be vigilant about monitoring its use.

Storage and Handling

The product is supplied in a specific container designed to maintain its integrity and quality. To prevent misuse and ensure optimal preservation, it is imperative that the container remains unchanged.

Storage conditions should be monitored closely to maintain product efficacy. It is recommended to store the product in a controlled environment, adhering to the specified temperature ranges. Special handling precautions should be observed to avoid any potential degradation of the product.

Additional Clinical Information

The product is administered via the dental route, with patients advised to hold approximately 10-15 ml in their mouth for about 30 seconds before spitting it out and brushing their teeth. Clinicians should counsel patients to avoid swallowing the product and to rinse their mouths thoroughly after use.

For pediatric use, particularly in children under six years of age, a small amount of toothpaste, roughly the size of a pea, should be used under adult supervision to prevent swallowing. In the event of a large ingestion by a child, immediate consultation with a physician or dentist is recommended. The product contains sodium benzoate, which may cause slight irritation to the skin, eyes, and mucous membranes. It is essential to keep the product out of reach of young children and to avoid altering the container to prevent misuse and maintain quality. Additionally, the presence of fluoride necessitates guidance from parents or guardians when used by children.

Drug Information (PDF)

This file contains official product information for Dr. Dental Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)